AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Matching Primary Tumor and Blood Gene Expression Analysis of HPV-negative Squamous Head and Neck Cancers

Recruitingn/aAges 18 Years - anyAllFondazione IRCCS Istituto Nazionale dei Tumori, Mโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to learn whether a blood test can show the same biological features as the tumor in people with head and neck cancer that is not caused by HPV. These cancers often have different biological types, and these types may help predict how the cancer will behave. Today, these types can only be found by studying tumor tissue. This study wants to see if a simple blood sample can give the same information. The main questions the study aims to answer are: * Can a blood test identify the same tumor type that researchers find by studying tumor tissue under a microscope and through genetic testing? * Can these blood test results help predict how people may do after finishing treatment? Researchers will not assign treatments. All participants will receive the treatments recommended by their own care team as part of routine care. Participants will: * Give a

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Pathologic diagnosis of HNSCC * Primary HNSCC arising from the following sites of head and neck: oral cavity, p16-negative oropharynx, hypopharynx, larynx * Stage III-IVa/b according to the eighth edition of AJCC/UICC classification * Treatment with curative intent * Unequivocal clinical and/or radiological absence of metastatic disease * Patient ability and availability to comply with study protocol procedures.- Exclusion Criteria: * Recurrent/metastatic HNSCC * p16+ oropharyngeal squamous cell carcinoma * Evidence of high-risk HPV infection at tumor level * Cancer of unknown primary site * Non-squamous head and neck cancers (e.g., lymphoma, sarcoma, melanoma, salivary gland cancers) * Skin squamous cell carcinoma from the skin of the head and neck * Nasopharyngeal carcinoma * Sinonasal/paranasal cancers * Insufficient data about previous medical history.
๐Ÿ’Š

What it tests

  • Standard of Care (Investigator Choice)
๐Ÿ“

Where

2 sites
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy
Azienda Ospedaliera Universitaria di Sassari
Sassari, Italy
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy